Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20537151 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: Human anti-TNF monoclonal antibody/adalimumab

Indicates status has not been verified in more than two years